CerilliantLog In | Recently Purchased | Favorites | My COAs | Cart (0)Cerilliant ISO


27-December-2011
Cerilliant introduces Zonisamide-13C6 and Cannabinol-D3 as its newest Snap-N-Spike® internal standards.

Zonisamide-13C6, 100 µg/mL Z-006
100 ug/mL in Methanol

Zonisamide is a second-generation anticonvulsant approved for use as an adjunctive therapy in adults with partial-onset seizures, infantile spasm, mixed seizure types of Lennox-Gastaut syndrome, and generalized tonic clonic seizure. Zonisamide is marketed in the US under the trade name Zonegran®.

Cannabinol-D3, 100 µg/mL C-115
100 ug/mL in Methanol

Cannabinol is a cannabinoid found in the cannabis plant as well as a metabolite of Δ9-THC, the main psychoactive component of cannabis. Cannabinol is also the primary product of THC degradation from exposure to air and light.

These internal standards are suited for GC/MS or LC/MS method applications from clinical toxicology and forensic analysis to urine drug testing and isotope dilution methods.


Cerilliant Certified Solution Standards and Certified Spiking Solutions are manufactured to the highest industry standards. We are accredited to ISO Guide 34 and ISO/IEC 17025 & certified to ISO 13485 and ISO 9001. Our quality system also incorporates cGMP and GLP requirements


All New Product Announcements


© 2018 Cerilliant Corporation | 811 Paloma Drive, Suite A | Round Rock, Texas 78665
Sigma-Aldrich is a subsidiary of Merck KGaA, Darmstadt, Germany
Products | News/Events | Sitemap | Privacy Policy | EHS Policy | Terms & Conditions | Contact
Follow Us: Cerilliant Linkedin LinkedIn